Various findings on CT can indicate how far a patient has progressed along disease timeline.
An axial CT image obtained without intravenous contrast in a 42‐year‐old male in the “late” time group (10 days from symptom onset to this CT) shows bilateral consolidative opacities, with a striking peripheral distribution in the right lower lobe (solid arrows), and with a rounded morphology in the left lower lobe (dashed arrow). Image Courtesy: Radioloy Online
How frequently certain findings show up on a CT scan of a person infected with the coronavirus disease 19 (COVID-19) is directly related to where they are on the disease timeline.
In a new study published in Radiology, investigators from Mount Sinai Health System determined that various CT findings were more common at certain points during disease progression.
“Recognizing imaging patterns based on infection time course is paramount for not only understanding the pathophysiology and natural history of infection, but also for helping to predict patient progression and potential complication development,” wrote lead study author Adam Bernheim, M.D., assistant professor of diagnostic, molecular, and interventional radiology at Icahn School of Medicine at Mount Sinai.
Even though real-time reverse transcriptase polymerase chain reaction (rRT-PCR) kits can be used to diagnose COVID-19, many centers don’t have access to enough kits, and they also carry a possibility of false negative results. Consequently, Chinese health officials have largely recommended relying on clinical and chest CT findings for diagnosis.
To identify common CT findings based upon the time between symptom onset and initial CT exam, the research team analyzed chest CTs from 121 patients (61 men and 60 women) who had been diagnosed with and exhibited symptoms of COVID-19 from four centers in China from Jan. 18, 2020, to Feb. 2, 2020.
For 94 participants, researchers knew the time between the initial emergence of symptoms and a chest CT – early (0-2 days), intermediate (3-5 days), and late (6-12 days). Among those who were imaged early, the team found ground-glass abnormalities, as well as “crazy paving” development. A lack of ancillary chest CT findings, including lymphadenopathy, pleural effusions, pulmonary nodules, and lung cavitation is also characteristic of early COVID-19 cases. Individuals further along in the disease course exhibited increasing consolidation.
Further research is required to evaluate CT scan findings in chronic patients, according to the authors. The analysis could determine if long-term complications emerge.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
2 Commerce Drive
Cranbury, NJ 08512